- Home
- AUR vs EXAS Comparison
AUR vs EXAS Comparison
Compare AUR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUR
- EXAS
- Stock Information
- Founded
- AUR 2017
- EXAS 1995
- Country
- AUR United States
- EXAS United States
- Employees
- AUR N/A
- EXAS N/A
- Industry
- AUR EDP Services
- EXAS Medical Specialities
- Sector
- AUR Technology
- EXAS Health Care
- Exchange
- AUR Nasdaq
- EXAS Nasdaq
- Market Cap
- AUR 9.6B
- EXAS 10.1B
- IPO Year
- AUR N/A
- EXAS N/A
- Fundamental
- Price
- AUR $6.42
- EXAS $48.49
- Analyst Decision
- AUR Buy
- EXAS Strong Buy
- Analyst Count
- AUR 9
- EXAS 20
- Target Price
- AUR $10.25
- EXAS $70.26
- AVG Volume (30 Days)
- AUR 24.6M
- EXAS 2.6M
- Earning Date
- AUR 07-30-2025
- EXAS 08-06-2025
- Dividend Yield
- AUR N/A
- EXAS N/A
- EPS Growth
- AUR N/A
- EXAS N/A
- EPS
- AUR N/A
- EXAS N/A
- Revenue
- AUR N/A
- EXAS $2,828,128,000.00
- Revenue This Year
- AUR N/A
- EXAS $14.61
- Revenue Next Year
- AUR $908.95
- EXAS $12.65
- P/E Ratio
- AUR N/A
- EXAS N/A
- Revenue Growth
- AUR N/A
- EXAS 11.57
- 52 Week Low
- AUR $3.25
- EXAS $39.97
- 52 Week High
- AUR $10.77
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- AUR 62.93
- EXAS 38.76
- Support Level
- AUR $5.98
- EXAS $48.15
- Resistance Level
- AUR $6.64
- EXAS $53.95
- Average True Range (ATR)
- AUR 0.29
- EXAS 2.10
- MACD
- AUR 0.12
- EXAS -0.51
- Stochastic Oscillator
- AUR 85.15
- EXAS 4.39
About AUR Aurora Innovation Inc.
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.